Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient

Overview of attention for article published in Journal of Neurology, May 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

blogs: 1 blog

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 27 Mendeley

Summary Blogs Dimensions citations

So far, Altmetric has seen 1 blog post.

Clinic Speak: switching from fingolimod to alemtuzumab

Multiple Sclerosis Research, 07 May 2014

Switching from fingolimod to alemtuzumab #ClinicSpeak #MSBlog #MSResearch"My post on switching from natalizumab to alemtuzumab…